Dr John D Gawlik, MD in Irvington, NJ - General Practice

Dr John D Gawlik, MD is a General Practice physician based in Irvington, New Jersey. Dr John D Gawlik is licensed to practice in New Jersey (license number 25MA03348100) and his current practice location is 464 Chapman St, Irvington, New Jersey. He can be reached at his office (for appointments etc.) via phone at (973) 399-7820.

NPI number for Dr John D Gawlik is 1720209091 and his current mailing address is 464 Chapman St, Irvington, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1720209091.

Contact Information

	Dr John D Gawlik, MD
	464 Chapman St, Irvington, NJ 07111-1502
	(973) 399-7820
	Not Available

Physician's Profile

Full Name	Dr John D Gawlik
Gender	Male
Speciality	General Practice
Location	464 Chapman St, Irvington, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1720209091
Provider Enumeration Date: 05/02/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr John D Gawlik such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720209091	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	25MA03348100 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John D Gawlik is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John D Gawlik, MD 464 Chapman St, Irvington, NJ 07111-1502 Ph: (973) 399-7820	Dr John D Gawlik, MD 464 Chapman St, Irvington, NJ 07111-1502 Ph: (973) 399-7820

News Archive

ASTRO to honor David Larson and William McBride with prestigious Gold Medal award

David Larson, M.D., Ph.D., FASTRO, and William McBride, D.Sc., Ph.D., have been chosen to receive the American Society for Radiation Oncology's most prestigious award, the Gold Medal. They will be presented with this honor at the Awards Ceremony during ASTRO's 52nd Annual Meeting, taking place October 31 to November 4, 2010, in San Diego.

Welch Allyn, Cerner to deliver connected solution for patient data management

Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, and Cerner Corporation, a company dedicated to contributing to the systemic change of health and care delivery, have collaborated to deliver a connected solution that can help clinicians overcome common issues like inaccuracy, poor data management and inefficient workflow.

State roundup: Mass. cost control plan advances; Texas Senate's abortion bill vote; Miami's public hospital crisis

The governor of Massachusetts proposed changes on Thursday to the state's comprehensive healthcare program, one often seen as a prototype for national reforms, to attempt to bring rising costs under control. The plan would give the U.S. state more authority to scrutinize fees paid to hospitals and doctors, reform the current standard by which healthcare providers are compensated and enact medical malpractice reform.

BARDA awards contracts for development of drugs to treat injuries associated with acute radiation syndrome

Two contracts for advanced development of drugs to treat skin and lung injuries associated with acute radiation syndrome (ARS) were awarded this week by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA). These contracts are the first by BARDA to address the skin and lung injuries that arise from acute exposure to high levels of ionizing radiation - the type of radiation that results from a nuclear blast.

NEJM studies lead to drop in vertebroplasty and vertebral augmentation procedures

Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that vertebroplasty and vertebral augmentation (which includes kyphoplasty) procedures have dropped 10% following the August 2009 publication of two studies in the New England Journal of Medicine (NEJM).

Dr John D Gawlik, MD - General Practice in Irvington, NJ